Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cycloset Safety Trial
NCT00377676Phase 3Completed
- Sponsor
- VeroScience
- Start
- Jul 2004
- Primary completion
- Jan 2007
- Modality
- Orthosteric Ligands
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Cycloset + UDT with Placebo + UDT (2 arms). Primary endpoint: Subjects Experiencing Serious Adverse Events at 52 weeks. Started Jul 2004; status: completed.
02
Drugs
bromocriptine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00377676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00377676.